查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1138376

疝气修復设备的全球市场-2022-2029

Global Hernia Repair Devices Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场动态

对疝气修復设备开发的资金和投资不断增加，预计将推动市场增长。

一些公司已经筹集或投资于疝气修復设备的开发。例如，2020年1月，Virtual Incision Corporation宣布获得2000万美元的B+轮融资，由投资者Bluestem Capital领投，回归投资者PrairieGold Venture Partners和Genesis Innovation Group等相关投资者参投。这笔资金将用于各种应用，包括疝修补术、胆囊切除术、抗反流手术、脾切除术、肾上腺切除术、胃袖、胃旁路术、子宫切除术和肝胰胆管手术 (MIRA)。）将用于支持导致手术机器人平台商业化的监管和临床计划。因此，从上述陈述来看，预计将在预测期内推动市场。

与使用疝气修復设备相关的副作用预计会阻碍市场增长。

市场受到与使用疝气修復设备相关的副作用的阻碍。在接受疝气修復装置治疗的患者中观察到一些副作用，包括疼痛、感染、復发、粘连、肠梗阻和器官穿孔。据英国外科杂誌报导，疝气网状涂层减少了一周的粘连。 1 个月后，疝网涂层未观察到粘连预防。此外，网状物穿过身体，导致肠梗阻。根据美国食品和药物管理局 (FDA) 的说法，再生网片是患者肠道前庭形成和梗阻的主要原因。还观察到慢性感染，例如炎症、发烧和其他类似流感的症状。根据美国食品和药物管理局 (FDA) 的说法，Ethicon Physiomesh 植入物在患者之间发生了分层和迁移。这种植入物附着在患者的肠道和皮肤上。这种植入物迁移导致过度疼痛和严重损伤。

COVID-19 影响分析

全球疝气修復设备市场受到 COVID-19 大流行的影响。随着感染 COVID-19 的患者数量增加，接受疝修补手术的患者数量正在下降。 COVID-19 可能对角膜手术的性能构成严重威胁。在全球范围内，由于接受疝气修復手术的人数减少，由于 COVID-19 流行，对疝气修復设备的需求有所下降。根据 F. Kockerling 等人 2020 年的数据，在 COVID-19 中断的 12 周高峰期间，约有 2800 万例择期手术被取消。根据疝气登记处的数据，由于 COVID-19 流行，腹股沟疝修补术已从 2020 年 2 月的 6,699 例减少到 2020 年 6 月的 3,033 例。脐疝修復从 2020 年 2 月的 1,692 例减少到 2020 年 6 月的 1,421 例。

行业分析

疝气修復设备市场根据各种行业因素（包括未满足的需求、定价分析、供应链分析和监管分析）对市场进行了深入分析。

全球疝气修復设备市场报告提供大约 45 多个市场数据表、40 多个数字和 180 页的组成。

内容

第1章研究方法与范围

  • 调查方法
  • 调查目的和范围

第 2 章定义和概述

第 3 章执行摘要

  • 按产品类型划分的市场细分
  • 按疝气类型划分的市场细分
  • 市场细分：按治疗区域
  • 按治疗类型划分的市场细分
  • DataM CLO 场景

第 4 章力学

  • 市场影响因素
  • 驱动程序
    • 在疝气修復手术中越来越多地采用网片
    • 新产品开发
  • 限制因素
    • 网格成本高
    • 产品缺陷风险
  • 商机
  • 影响分析

第5章疝气修復器械行业分析

  • 波特五力分析
  • 供应链分析
  • 定价分析
  • 监管分析
  • 专利分析

第 6 章按产品类型

  • 网格和补丁
    • 天然材料
    • 合成
  • 内窥镜设备
    • 心电图仪
    • X 射线
    • 其他
  • 手术设备
    • 缝合
    • 抓手
    • 剪刀
    • 促针因子
    • 其他
  • 其他
    • 植入
    • 存取和解剖装置
    • 灌溉配件

第 7 章疝型

  • 腹股沟疝
    • 腹股沟直疝
    • 间接腹股沟疝
  • 裂孔疝
  • 脐疝
  • 切口疝
  • 股疝
  • 脊椎疝
  • 腋下/腰椎疝
  • 腹壁疝

第 8 章按治疗部位类型

  • 腹部
    • 腹股沟直疝
    • 间接腹股沟疝
  • 大腿上部
  • 腹部
  • 腹股沟

第 9 章治疗

  • 腹腔镜手术
    • 腹股沟直疝
    • 间接腹股沟疝
  • 张紧修復
  • 无张力修復
  • 机器人手术
  • 腹部重建

第 10 章按地区划分

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第 11 章竞争格局

第 12 章竞争格局

  • 竞争场景
  • 竞争对手战略分析
  • 产品组合比较分析
  • 市场情况/份额分析
  • 併购分析

第 13 章公司简介

  • 美敦力公司
    • 公司简介
    • 产品组合和描述
    • 主要亮点
    • 财务摘要
  • B. Braun Melsungen AG
  • Cook Inc.
  • C.R. Bard
  • Integra Lifesciences Holdings Corporation
  • Baxter International Inc.
  • Cooper Surgical Inc.
  • Lifecell Corporation
  • Stryker Corporation
  • Atrium Medical Corporation

第14章 DataM

简介目录
Product Code: DMMD1249

Market Overview

Hernia Repair Devices Market size was valued US$ YY million in 2021 and is estimated to reach US$ YY million by 2029, growing at a CAGR of 5.65% during the forecast period (2022-2029).

Hernia is the condition in which the internal organ or fatty tissue surges out through the fascia, a weak spot present in a surrounding muscle or connective tissue. A hernia occurs most frequently within the abdominal cavity, between the chest and the hips. Inguinal hernia, femoral hernia, umbilical hernia, hiatal hernia, and others are the most prevalent hernia observed across the globe. A hernia is characterized by the signs and symptoms such as swelling in the groin or scrotum, pain at the site of the bulge, pain while lifting, increased bulge size over time, aching sensation, and bowel obstruction.

Hernia repair devices are the devices that are used for performing the surgical procedure for the correction of hernia. Hernia repair devices are used for performing laparoscopic and open repair surgery. The market is dominated by the availability of hernia mesh, including synthetic mesh & biologic mesh, and mesh fixators, including the sutures, tack applicators, and glue applicators.

Market Dynamics

Increasing funding & investment for the development of the Hernia Repair Devices is expected to drive market growth.

Several companies are raising the funding and investment for developing the Hernia Repair Devices. For instance, in January 2020, Virtual Incision Corporation raised USD 20 million in a Series B+ financing round led by the investor Bluestem Capital, with participation from returning investor PrairieGold Venture Partners and Genesis Innovation Group and other affiliated investors. This funding would be used to support the regulatory and clinical programs leading to the commercialization of the miniaturized in vivo robotic assistant (MIRA) Surgical Robotic Platform for various applications such as hernia repair, gallbladder removal, anti-reflux surgery, splenectomy, adrenalectomy, gastric sleeve, gastric bypass, hysterectomy, and hepato-pancreato-biliary procedures. Thus, from the above statements, the market is expected to drive in the forecast period.

Adverse Effects Associated with using Hernia Repair Devices are expected to hamper the market growth.

The market is hindered by the adverse effects associated with the use of hernia repair devices. Several adverse effects were observed among patients treated with hernia repair devices, such as pain, infection, recurrence, adhesion, bowel obstruction, organ perforation, and other adverse effects. According to the British Journal of Surgery, the hernia mesh's coating has reduced the adhesion for a week. There was no adhesion prevention through the hernia mesh coating after a month. Mesh also leads to bowel obstruction as it can migrate in the body. According to the Food and Drug Administration (FDA), the recalled mesh is the leading cause of bowel preformation and obstruction among patients. Chronic infections such as inflammation, fever, and other flu-like symptoms are observed among the patients. According to the Food and Drug Administration (FDA), the Ethicon physiomesh implant was detached and migrated among the patients. This implant was attached to the patient's intestine and the skin. Migration of the implant resulted in excess pain and severe damage.

COVID-19 Impact Analysis

The global hernia repair devices market has been impacted due to the COVID-19 pandemic as there is decreased number of the patients undergoing the hernia repair surgeries with the increasing number of people suffering from the COVID-19. The COVID-19 can be a serious threat for carrying out the corneal surgery. Globally, the demand of the hernia repair devices has reduced due to COVID-19 pandemic with the decrease in the number of the people undergoing the hernia repair surgery. According to the F. Kockerling et.al. 2020, approximately, 28 million elective operations were cancelled during the peak 12 weeks of disruption occurred due to COVID-19. According to the hernia registry, the number of inguinal hernia repair surgery had witnessed the decreased from the 6,699 surgeries in February 2020 to 3033 in June 2020 due to COVID-19 pandemic. The number of the umbilical hernia repair surgeries has decreased from 1, 692 in February 2020 to 1,421 in June 2020.

Industry Analysis

The hernia repair devices market provides in-depth analysis of the market based on various industry factors such as unmet needs, pricing analysis, supply chain analysis, regulatory analysis etc.

Segment Analysis

The hernia mesh segment is expected to hold the largest share in the hernia repair devices market.

The hernia mesh segment accounted for holding the largest share in the hernia repair devices market due to the rising penetration of the hernia mesh. As per Sanders DL et al., yearly, around 20 million prosthetic meshes are implanted among patients with hernias worldwide. Every year nine out of ten hernia surgeries are performed using the hernia mesh in the United States. Hernia mesh supports the damaged tissue around hernias. It can be easily placed around the hernia by attaching it with stitches, staples, or glue. Hernia mesh comprises synthetic materials that can be absorbable, non-absorbable or a combination of both materials found in knitted mesh or non-knitted sheet forms. Hernia mesh is effective in lowering the recurrence of the hernias. The market is dominated by the availability of several hernia mesh products. For instance, Atrium comprises the several hernia mesh product portfolio such as C-QUR, Vitamesh, Proloop, Prolite, and Prolite UltraQ; B. Braun comprises the several hernia mesh portfolio such as Premilene, Omyra, Optilene; LifeCell Corporation comprises the hernia mesh product portfolio such as Alloderm Select, Strattice; and Medtronic comprised of the hernia mesh product portfolio such as Parietex, Permacol, ProGrip, Symbotex, Versatex.

Geographical Analysis

North American region is expected to hold the largest market share in the global hernia repair devices market.

North America dominated the global hernia repair devices market. It accounted for the largest market share in 2021, owing to the increasing adoption of hernia repair devices for performing hernia repair surgeries. According to Raquel Maia et al. 2021, published in Annals of Laparoscopic and Endoscopic Surgery, around 350,000 abdominal wall hernia repair surgeries were performed in a year. There is a high recurrence rate of hernias. The United States accounts for the highest market share due to the availability of favorable reimbursement policies for hernia repair surgeries. There is the presence of several market players developing advanced hernia repair devices. For instance, Ariste Medical gained 510(k) authorization from the US Food and Drug Administration in April 2022 to market their drug-embedded, synthetic hernia mesh in the US.

Competitive Landscape

Major key players in the hernia repair devices market are Medtronic Plc, Ethicon Inc., Atrium, Lifecell Corporation, B Braun Melsungen AG, Baxter International, Inc., Cook Medical, Becton, Dickinson and Company, CooperSurgical Inc., Insightra Medical, Inc., Olympus Corporation, and Integra Lifesciences.

Medtronic Plc:

Overview:

Medtronic plc is an American-Irish registered medical device company primarily operating in the United States. It has an operational and executive headquarters in Fridley, Minnesota, in the US. Moreover, it develops and manufactures devices and therapies to treat more than 30 chronic diseases, including heart failure, Parkinson's disease, urinary incontinence, Down syndrome, obesity, chronic pain, spinal disorders and diabetes. It is operated in 140 countries and employs over 104,950 people.

Product Portfolio:

Dextile Anatomical Mesh: Dextile anatomical mesh offers:

  • 3-D patented anatomical shape conforms with each side of the inguinal anatomy contours.
  • Wide coverage of the myopectineal orifice to minimize the risk of recurrence.
  • Exclusive structure to maintain shape after trocar passage.
  • Large pore size supports excellent tissue ingrowth and visualization of surrounding anatomy during surgery.

The global hernia repair devices market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Market Snippet By Product type
  • 3.2. Market Snippet By Hernia type
  • 3.3. Market Snippet By Therapeutic area type
  • 3.4. Market Snippet By Treatment type
  • 3.5. DataM CLO Scenario

4. Dynamics

  • 4.1. Market Impacting Factors
  • 4.2. Drivers
    • 4.2.1. Increasing adoption of mesh in hernia repair surgeries
    • 4.2.2. New product developments.
  • 4.3. Restraints
    • 4.3.1. High cost of meshes
    • 4.3.2. Risk of product failures
  • 4.4. Opportunity
  • 4.5. Impact Analysis

5. Hernia Repair Devices Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Patent Analysis

6. By Product type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product type Segment
    • 6.1.2. Market Attractiveness Index, By Product type Segment
  • 6.2. Mesh & Patch
    • 6.2.1. Introduction
      • 6.2.1.1. Natural
      • 6.2.1.2. Synthetic
    • 6.2.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
  • 6.3. Endoscopy Instruments
    • 6.3.1. Electrocardiogram
    • 6.3.2. X-ray
    • 6.3.3. Others
  • 6.4. Surgical Instruments
    • 6.4.1. Sutures
    • 6.4.2. Graspers
    • 6.4.3. Scissors
    • 6.4.4. Needle drivers
    • 6.4.5. Others
  • 6.5. Others
    • 6.5.1. Implants
    • 6.5.2. Access and Dissection devices
    • 6.5.3. Irrigation accessories

7. By Hernia type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Hernia type Segment
    • 7.1.2. Market Attractiveness Index, By Hernia type Segment
  • 7.2. Inguinal hernia
    • 7.2.1. Introduction
      • 7.2.1.1. Direct Inguinal hernia
      • 7.2.1.2. Indirect Inguinal hernia
    • 7.2.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
  • 7.3. Hiatal hernia
  • 7.4. Umbilical hernia
  • 7.5. Incisional hernia
  • 7.6. Femoral Hernia
  • 7.7. Spigelian Hernia
  • 7.8. Flank/Lumbar Hernia
  • 7.9. Epigastric Hernia

8. By Therapeutic area type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapeutic area Segment
    • 8.1.2. Market Attractiveness Index, By Therapeutic area Segment
  • 8.2. Abdomen
    • 8.2.1. Introduction
      • 8.2.1.1. Direct Inguinal hernia
      • 8.2.1.2. Indirect Inguinal hernia
    • 8.2.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
  • 8.3. Upper Thigh
  • 8.4. Belly button
  • 8.5. Groin

9. By Treatment

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Segment
    • 9.1.2. Market Attractiveness Index, By Treatment Segment
  • 9.2. Laparoscopic Surgery
    • 9.2.1. Introduction
      • 9.2.1.1. Direct Inguinal hernia
      • 9.2.1.2. Indirect Inguinal hernia
    • 9.2.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
  • 9.3. Open Tension Repair
  • 9.4. Non Tension Repair
  • 9.5. Robotic Repair
  • 9.6. Abdominal Wall Reconstruction

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product type
    • 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Hernia type
    • 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapeutic area
    • 10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment
    • 10.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Countries
      • 10.2.7.1. The U.S.
      • 10.2.7.2. Canada
      • 10.2.7.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product type
    • 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Hernia type
    • 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapeutic area
    • 10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment
    • 10.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Countries
      • 10.3.7.1. Germany
      • 10.3.7.2. U.K.
      • 10.3.7.3. France
      • 10.3.7.4. Italy
      • 10.3.7.5. Spain
      • 10.3.7.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product type
    • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Hernia type
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapeutic area
    • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment
    • 10.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Countries
      • 10.4.7.1. Brazil
      • 10.4.7.2. Argentina
      • 10.4.7.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product type
    • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Hernia type
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapeutic area
    • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment
    • 10.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Countries
      • 10.5.7.1. China
      • 10.5.7.2. India
      • 10.5.7.3. Japan
      • 10.5.7.4. Australia
      • 10.5.7.5. Rest of Asia Pacific
  • 10.6. The Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product type
    • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Hernia type
    • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapeutic area
    • 10.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment

11. Competitive Landscape

12. Competitive Landscape

  • 12.1. Competitive Scenario
  • 12.2. Competitor Strategy Analysis
  • 12.3. Comparative Product Portfolio Analysis
  • 12.4. Market Positioning/Share Analysis
  • 12.5. Mergers and Acquisitions Analysis

13. Company Profiles

  • 13.1. Medtroinc Plc
    • 13.1.1. Company overview
    • 13.1.2. Product portfolio and description
    • 13.1.3. Key highlights
    • 13.1.4. Financial overview
  • 13.2. B. Braun Melsungen AG
  • 13.3. Cook Inc.
  • 13.4. C.R. Bard
  • 13.5. Integra Lifesciences Holdings Corporation
  • 13.6. Baxter International Inc.
  • 13.7. Cooper Surgical Inc.
  • 13.8. Lifecell Corporation
  • 13.9. Stryker Corporation
  • 13.10. Atrium Medical Corporation

14. DataM Intelligence

  • 14.1. Appendix
  • 14.2. About Us and Services
  • 14.3. Contact Us